The Reuters news agency dedicated a long and documented article to the most recent studies on Covid-19 underway in the worl, which has been taken up by the main international newspapers.

One of the topics addressed is organ transplantation from deceased donors, infected with active SARS-CoV-2. There is two teams working on this to outline the experimental protocols that will be presented at the European Congress of Clinical Microbiology and Infectious Diseases from 23 to 26 April in Lisbon: one team led by Dr. Cameron Wolfe and Emily Eichenberger, from Duke University Medical Center in North Carolina and the team lead by Paolo Grossi, full professor of infectious diseases at the University of Insubria and director of the Structure of infectious and tropical diseases of the “Asst dei Sette Laghi di Varese”.
"The transplant community will undoubtedly learn more about the use of various organs from donors with recent or active COVID-19, over the course of 2022” – Grossi wrote in an advance copy of his presentation seen by Reuters - Although the published data are encouraging, the safety of donated organs in this scenario has yet to be proven given the small sample size of published studies."

➡️ Read the Reuters article "COVID SCIENCE-Risk of type 2 diabetes rises after COVID; organ transplant from donors who had COVID likely safe"